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-Synuclein (AS) is an intrinsically disordered protein highly
expressed in dopaminergic neurons. Its amyloid aggregates are
themajor component of Lewy bodies, a hallmark of Parkinson’s
disease (PD). AS is particularly exposed to oxidation of its
methionine residues, both in vivo and in vitro. Oxidative stress
has been implicated in PD and oxidized -synuclein has been
shown to assemble into soluble, toxic oligomers, rather than
amyloid fibrils. However, the structural effects of methionine
oxidation are still poorly understood. In this work, oxidized AS
was obtained by prolonged incubations with dopamine (DA) or
epigallocatechin-3-gallate (EGCG), two inhibitors of AS aggre-
gation, indicating that EGCGpromotes the same final oxidation
product as DA. The conformational transitions of the oxidized
and non-oxidized protein were monitored by complementary
biophysical techniques, including MS, ion mobility (IM), CD,
and FTIR spectroscopy assays. Although the two variants dis-
played very similar structures under conditions that stabilize
highly disordered or highly ordered states, differences emerged
in the intermediate points of transitions induced by organic sol-
vents, such as trifluoroethanol (TFE) and methanol (MeOH),
indicating a lower propensity of the oxidized protein for form-
ing either - or -type secondary structures. Furthermore, oxi-
dizedASdisplayed restricted secondary-structure transitions in
response to dehydration and slightly amplified tertiary-struc-
ture transitions induced by ligand binding. This difference in
susceptibility to induced folding could explain the loss of fibril-
lation potential observed for oxidized AS. Finally, site-specific
oxidation kinetics point out aminor delay inMet-127modifica-
tion, likely due to the effects of AS intrinsic structure.
-Synuclein (AS)4 is a 140-residue, intrinsically disordered
protein (IDP) (1) highly expressed in the presynaptic nerve ter-
minals, where it plays a regulatory role in synaptic homeostasis
(2–4). Three regions can be recognized in its primary structure:
the N-terminal region, capable to bindmembranes undergoing
coil-to-helix transitions; the central, hydrophobic region in-
volved in amyloid fibril formation; and the C-terminal, acidic
region responsible for pH-dependent conformational transi-
tions and binding to multiple protein interactors. AS aggrega-
tion is a hallmark of PD and related neurodegenerative
disorders. AggregatedAS is themajor component of Lewy bod-
ies and AS mutations or altered expression correlate with
increased risk of PD onset (4).
AS oxidation has been long implicated in PD. However, the
underlying molecular mechanisms are not clear yet. Due to the
oxidative challenge represented by DA, dopaminergic neurons
are particularly exposed to protein oxidative damage. AS can be
oxidized on its four methionine residues (positions 1, 5, 116,
and 127), in vivo and in vitro (5). Typical effective oxidants are
DA, via its oxidation products, and H2O2 (6–9). Methionine-
oxidized AS is inhibited in fibrillation and, rather, aggregates
into soluble, SDS-resistant oligomers with variable degrees of
cytotoxicity (9–12).Methionine sulfoxide epimers can be enzy-
matically reduced in vivo by the activity ofmethionine sulfoxide
reductase (13). In-cell NMR, however, has shown that only
Met-1 and Met-5 are restored in oxidized AS, whereas C-ter-
minal positions 116 and 127 are not targeted by the cellular
repair machinery in mammalian cells, which could lead to the
accumulation of toxic species (14).
Protein oxidation onmethionine residues to give sulfoxide is
thought to affect protein function mainly via structural effects
(5). The modification causes, indeed, a remarkable loss of
hydrophobic character of the methionine side chain, which
could affect secondary and tertiary structure (7). Furthermore,
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methionine oxidation results in a lower intrinsic propensity for
helical structures as shown on poly-Met polymers (15). To
interpret the biological responses to AS oxidation, it is impor-
tant to understand the effect of methionine oxidation per se on
AS conformational transitions, dissecting it from other, fre-
quently associated processes like protein–protein and protein–
membranes interactions or other AS covalent modifications.
Based on CD spectroscopy, fully oxidized (oMet4) AS
appears to be slightly more disordered than non-oxidized
(oMet0) AS, with very minor losses of intrinsically formed hel-
ical segments (7). However, the spectra are almost superimpos-
able and imprinted to a general character of highly disordered
protein (7, 14, 16). On the other hand, both proteins are highly
helical in the presence of a strong molar excess of docosa-
hexaenoic acid (DHA), with oMet4 AS displaying a similar hel-
ical content as oMet0 AS (17). Nevertheless, a conceivable
hypothesis is that oxidation impacts on AS propensity to
acquire ordered secondary/tertiary structure (7). Such a mech-
anism could be at the basis of different propensities of reduced
and oxidized AS to populate the amyloidogenic conformer that
triggers fibrillation. An indication of different conformational
transitions of the two protein variants derives fromNMR anal-
ysis of the helicity induced byN-terminal acetylation in the first
10 residues of the protein. The comparison of oMet4 and oMet0
AS indicates that oxidation inhibits the acetylation-induced
conformational transition in the N-terminal residues (18).
This work focuses on the characterization of AS oxidation
products to test the hypothesis that methionine oxidation
affects AS conformational transitions, despite the similar sec-
ondary structure displayed by oMet4 and oMet0 AS in highly
disordered or highly helical states. Oxidation is monitored
upon prolonged incubations with DA or EGCG. Both ligands
inhibit AS fibrillation and induce formation of oligomers (10,
19), which are not toxic in the case of EGCG (19). The two
ligands bind AS with distinct conformational selectivity, form-
ing noncovalent and non-oxidized complexes upon short incu-
bation time (20). However, it has been shown that AS can be
oxidized by DA (9, 10), and other proteins by EGCG (21), after
a long incubation time. Here, AS oxidation is monitored by
electrospray ionization MS (ESI-MS) and the monomeric, sol-
uble, fully oxidized product is analyzed by CD, FTIR spectros-
copy, and native MS, under conditions that promote either -
or -type secondary structure.
Results
Oxidation kinetics
AS susceptibility to covalentmodifications in the presence of
DA or EGCG has been investigated by incubating the protein
with either ligand at 37 °C under mild agitation. 2 mM DA and
200 M EGCG were used as previously characterized condi-
tions enabling effective detection of AS-ligand noncovalent
complexes (20). Aliquots were taken at different time points,
purified from salts and free ligand, and analyzed by ESI-MS
under denaturing conditions for intact protein detection. The
data reported in Fig. 1, A–C, show that, under prolonged incu-
bation, both ligands induce stepwise mass shifts of 16 Da in AS
peaks, corresponding to progressive oxidation states. Up to 4
oxidations per ASmolecule can be detected, which correspond
to the number of methionine residues in the molecule. The
species distributions evolve toward an almost homogeneous,
4-oxidized population after 72 h, with still10% of 3-oxidized
protein detectable in the presence of DA and20% in the pres-
ence of EGCG (Fig. 1, D and E). No covalent adducts with the
ligands are detectable under these conditions. These results
indicate that both ligands can induce AS oxidation.
To map the modification sites and describe their individual
kinetics, chymotryptic peptides from the same samples as
above were analyzed by ESI-MS (Fig. 2). Three oxidized methi-
onine residues (positions 1, 116, and 127, Table S1) were iden-
tified in samples incubated with either DA or EGCG by ESI-
MS/MS, indicating that the modification corresponds to
sulfoxidation (Fig. S1). Likely, the fourth modification involves
the peptide containing Met-5, which could not be identified in
either oxidized or non-oxidized forms and is presumably lost
during the purification procedure, due to its very small size.
Quantification of the oxidation extent was obtained by the
peak–height ratios between the oxidized and non-oxidized
forms of each detected peptide (Fig. 2, A–C, and Fig. S2).
To retrieve direct evidence on the oxidation state of all four
methionine residues, tryptic digests were analyzed as well (Fig.
2). This procedure generates an N-terminal peptide containing
Met-1 andMet-5 and aC-terminal peptide containingMet-116
andMet-127. The extent of oxidation at positions 1 and 5 could
be assessed from theMS/MS data, as the ratio between peptide
spectrummatches of the oxidized andnon-oxidized formof the
N-terminal peptide (Fig. 2, Figs. S3–S5, and Table S1). The use
of the MS/MS spectral counts method in place of the MS
precursor–ion peak–height made it possible to exactly calcu-
Figure 1. Oxidation kinetics of intact AS. A–C, ESI-MS peaks corresponding
to the15 charge state ofAS after a 24-h incubation in the absenceof ligands
(A), in the presence of DA (B), and in the presence of EGCG (C). In each panel
the peaks are labeled by the number of oxidized residues. (D and E): AS oxi-
dation extent (0, black; 1, red; 2, blue; 3, green; 4, magenta, oxidized methio-
nine residues) as a functionof the incubation time in thepresenceofDA (D) or
EGCG (E). Error bars indicate the standard deviation from three independent
experiments.
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late the contribution of single oxidation events on eitherMet-1
or Met-5, thus enabling measurement of the oxidation rate of
individualmethionine residues (Fig. S5). Thiswould not be pos-
sible using peak–height or peak–area calculations on the pre-
cursor ion, because the latter has the same m/z value whether
the single oxidation concerns Met-1 or Met-5. The C-terminal
tryptic peptide, instead, is too large to yield high-quality
MS/MS spectra by collision-induced dissociation, hindering
accurate sequence assignment and quantification of the oxida-
tion levels. Thus, the extent of oxidation at positions 116 and
127 was better calculated from MS data of the respective chy-
motryptic peptides (Fig. 2, A–C, Fig. S2). The list of the identi-
fied peptides by tryptic and chymotryptic digestions is reported
in Table S1.
The resulting, position-specific oxidation profiles are
reported in Fig. 2, D and E. It can be noticed that oxidation
kinetics at positions 1, 5, and 116 are quite similar and reach a
plateau around 40 h incubation under the conditions employed
here, with either ligand. Oxidation of Met-127, instead, is
slightly but systematically delayed relative to the others. It is
interesting to note that this residue belongs to the 125YEMPS129
motif, which has been implicated in long-range interactions
with the central NAC (non-amyloid- component) region and
interaction with DA and its oxidation products (22–26). These
local structural features are likely at the basis of the different
oxidation kinetics of the Met-127 residue.
Secondary-structure transitions
The conformational response of oMet0 and oMet4 AS to
organic solvents has been studied by far-UV CD. Under non-
denaturing conditions, the two species display a typical spectra
of intrinsically disordered proteins, characterized by a large
amount of random coil (minimum at 200 nm), with a small
-helical component (shoulder at 222 nm) (7) (Fig. 3A). The
addition of either TFE (Fig. 3, B and C) or MeOH (Fig. 3, E and
F) induces, respectively, the acquisition of - or -type second-
ary structures by oMet0, as previously described (27). Under the
same conditions, oMet4 AS displays a lower propensity to form
ordered secondary structure relative to oMet0 AS, with higher
concentrations of organic solvent being required to observe
similar effects. Moreover, the final secondary structure dis-
played by the two proteins at high solvent concentrations (15%
TFE and 40%MeOH), which correspond to the post-transition
spectra of oMet0 AS (27), are not identical. In both cases, oMet4
AS shows a lower content of ordered secondary structure, par-
ticularly in the case of methanol-induced -strands, as indi-
cated by the lower intensity of the signal at 215 nm.
AS incubation in the presence of DA is known to induce
formation of soluble, SDS-resistant oligomers. SDS-PAGE
analysis indicates that higher-order species are detectable, par-
ticularly upon EGCG treatment. Their amount in the samples
used here for CD titrations (Fig. 3D) is below 15%, as assessed
from densitometry analysis (data not shown). The absence of
bands in the pellet lanes of the gel rules out the presence of
aggregates that become soluble in SDS and the comparable
intensity of monomeric AS suggests that no significant amount
of material is lost in the pellet of the final sample clarification
after SDS solubilization. Some faint bands (8%) can be
detected at slightly lower molecular weight, likely due to some
proteolytic degradation. In conclusion, the observed structural
features can be ascribed to soluble, monomeric AS, which is the
largely predominant species in the analyzed samples. Dynamic
equilibrium with SDS-sensitive oligomeric species cannot be
ruled out, although it has not been described before, for AS
under similar conditions.
Secondary structure of oMet0 and oMet4 AS has been ana-
lyzed also by FTIR spectroscopy. The absorption and second-
derivative spectra of AS samples, measured in the form of pro-
tein films, are reported in Fig. 4, A and B, for the Amide I band,
which is mainly due to the stretching vibration of the peptide
bond (28). The main spectral component around 1657 cm1
can be assigned to random coil with possible contribution of
-helical structures. Two additional peaks are evident around
1696 and 1627 cm1. In agreement with a previous study, these
peaks can be assigned to -sheet structures induced by solvent
evaporation and protein–protein interactions in the film (29).
The oMet4 protein displays a lower intensity of such compo-
nent (Fig. 4, A and B), indicating a lower content of ordered
-structures compared with oMet0 AS.
The secondary structure of oMet0 and oMet4 AS has also
been studied here by conventional FTIR measurements of the
proteins in D2O solution (30, 31). The Amide I absorption and
second-derivative spectra of the two proteins in solution at
30 °C were superimposable (Fig. 4, C and D) and were charac-
terized by a main component around 1642 cm1 assigned to
random-coil structures (27–29, 32). These data for the protein
in solution are only in apparent contrast with those on protein
films and can be interpreted by a role of dehydration in the
Figure 2.Oxidationkinetics ofASmethionine residues.A–C, ESI-MSpeaks
corresponding to the 4 charge state of the AS chymotryptic peptide con-
taining Met-116, after 24-h incubation in the absence of ligands (A), in the
presenceofDA (B), and in thepresenceof EGCG (C).DandE,oxidation fraction
of each methionine residue (M1, black; M5, red; M116, blue; M127, green) as a
function of the incubation time in the presence of DA (D) or EGCG (E). Quan-
tification for Met-116 and Met-127 has been performed on MS data on chy-
motryptic peptides. Quantification for Met-1 and Met-5 has been performed
on MS/MS data on tryptic peptides. The black and red symbols are mostly
overlaid for the 40-h time point and beyond. Error bars indicate the S.D. from
at least three independent experiments.
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Figure 3. Secondary-structure transitions by CD spectroscopy. Far-UV CD spectra of oMet0 (black lines) and oMet4 (red lines) AS in the absence of organic
solvents (A); in the presence of 10% (B) and 15% (C) TFE; in the presence of 35% (E) and 40% (F) MeOH.D, SDS-PAGE analysis of supernatants (s) and pellets (p)
obtained from the following samples: ASbefore incubation (ref); AS after 72h incubation in the absenceof ligands (AS); AS after 72h incubation in thepresence
of DA (DA); AS after 72 h incubation in the presence of EGCG (EGCG). The bands corresponding to AS monomer, fragments, and oligomers are labeled.
Representative data from at least three independent experiments are shown.
Figure4. Secondary-structure transitionsbyFTIR spectroscopy.Absorption (A) and second-derivative (B) spectraof oMet0 (black lines) andoMet4 (red lines)
AS measured in the form of protein films obtained after solvent evaporation. C, absorption spectra of oMet0 and oMet4 ASmeasured in D2O solution at 30 °C.
Second-derivative spectra of oMet0 (D) and oMet4 (E) AS measured in D2O solution at different temperatures from 25 to 100 °C. Arrows point to the spectral
changes observed at increasing temperatures. The peak positions of the main components are shown. F, ratio of the intensity at 1655 and 1642 cm1 taken
from the second-derivative spectra of D and E. Representative data from 3 (A and B) or 2 (C–F) independent experiments are shown. Error bars indicate the
standard deviation.
-Synuclein oxidation hinders secondary structure formation
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observed response of semidry oMet4. Thus, oxidation per se is
not enough to induce major changes in AS secondary structure
in solution but it reduces its propensity to form ordered struc-
ture, as those induced by dehydration.
The conformational stability has been compared by applying
temperature ramps. The spectral changes induced by heating
the protein solutions from 25 to 100 °C are very similar for
oMet0 and oMet4 AS (Fig. 4, D–F). Therefore, FTIR analyses
detect comparable secondary structure and temperature
response for oMet0 and oMet4 AS inD2O solution (Fig. 4,C–F).
It has been pointed out that such spectral changes of IDPs could
also be interpreted as a loss of polyproline II-like structures,
rather than acquisition of -helices (33).
In conclusion, conformational properties of oMet0 and
oMet4 AS are very similar, as assessed by CD and FTIR. How-
ever, both techniques can capture differences under particular
conditions, always in the direction of a reduced propensity of
oMet4 to acquire ordered secondary structure.
Ligand binding
Native MS has been employed to evaluate the effects of oxi-
dation on ligand binding by AS. Ternary mixtures of oMet0,
oMet4, and either DA or EGCG have been analyzed by ESI-MS
under nondenaturing conditions, allowing for comparison
under identical conditions and direct protein competition for
the same ligand. The spectra reveal complexes for each protein
form, which can be distinguished by their distinct masses (Fig.
5). Ligand binding displays the same stoichiometry and the
same conformational selectivity for the two protein variants,
with preferential binding of DA to more extended conforma-
tions (charge states 10 to 14) and EGCG to more compact
forms (charge states 6 to 12), as already reported for the
non-oxidized protein (20). The apparent affinities of DA for
oMet0 and oMet4 seem to be comparable, too, because the
amounts of complexes at each binding step are very similar (as
seen for the 11 and 8 charge states in Fig. 5, C and D). The
latter has been chosen as the ion with the highest fraction of
bound EGCG. The 11 charge state for DA complexes has
been selected as the lowest charge state with significant ligand
bound, to prevent conformational artifacts induced by Cou-
lomb repulsions that can contribute to higher charge states
(20). These peaks are used for further analysis of the protein–
ligand complexes.
Figure 5. LigandbindingbynativeMS.A and B, ESI-MS spectra of ternarymixtures of oMet0, oMet4, and either DA (A) or EGCG (B). The 11 and 8peaks are
labeled by the corresponding charge state. C and D,magnification of A and B in the region of the 11 (C) and 8 (D) charge state. The peaks of oMet0 (black
symbols) and oMet4 (red symbols) are labeled by the number of ligandmolecules bound in the complex. Representative data from at least three independent
experiments are shown.
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To obtain amore detailed description of structural compact-
ness, the collision cross-section (CCS) of the protein and its
noncovalent complexes has been measured by nano-ESI ion
mobility (IM) MS and shown in Fig. 6. The observed segrega-
tion of DA and EGCG complexes in the charge state diffusion
reflects the previously reported (20) conformational selectivity
of the two different ligands. Multiple conformers with slightly
different compactness are distinguishable, even within the
same charge state.
For the 11 charge state (Fig. 6A), the free protein populates
almost exclusively the more compact conformer (b), irrespec-
tive of the oxidation state. As already shownpreviously (20), DA
binding stabilizes the more extended conformer (a), giving
larger CCS. The more DA molecules bound, the higher the
relative population of the a conformer. This effect is main-
tained in the oxidized protein variant, withminor differences. A
small amplification of the effect can be observed in the oxidized
form, with slightly larger fractions of the extended form detect-
able (Fig. 6). The effect, however, is barely significant (Table
S2).
The results for the 8 charge state show at least five different
conformers (c–g), consistent with an ensemble also featuring
collapsed forms (Fig. 6B). Oxidation seems to affect species dis-
tributions whether or not EGCG is bound. Even in the free
protein, the compact states below 2500 Å2 CCS are slightly
enriched in oMet4 relative to oMet0. As previously described
(20), EGCG binding to AS promotes formation of these com-
pact conformers (e–g). Oxidation amplifies such an effect, with
slightly larger fractions of the collapsed species detectable at
each stoichiometry (Fig. 6, Table S2).
Thus, oxidation seems to play subtle effect in AS tertiary-
structure transitions induced by ligands, with a slight ampli-
fication of the effects seen for the non-oxidized protein.
The difference, however, is only in the relative amounts
of the different conformers and not, apparently, in their
structure.
Discussion
Several lines of evidence suggest that DA inhibition of AS
fibrillation is mediated by methionine oxidation (8). In this
work it is shown that EGCG, another ligand with inhibitory
effects (19), inducesmethionine oxidation in AS, strengthening
the hypothesis that accumulation of oMet4 AS plays a central
role controlling the pathways of AS amyloid aggregation. The
oxidative effects ofDAandEGCGseem to be due to production
of H2O2 in the presence of oxygen and further accumulation of
the hydroxyl radical by the Fenton reaction in the presence of
even traces of Cu or Fe2 (5, 34). In addition, distinct effects
on AS conformation are induced by the formation of noncova-
lent complexes with DA and EGCG, with the stabilization of
different protein conformers upon ligand binding (20). These
ligand-specific effects could be responsible of further differ-
ences in the type of the predominant aggregation products.
Oxidative modifications induced by EGCG have been
described for other proteins (21), although apparently contrast-
ing evidence is reported in the literature. Indeed, EGCG dis-
plays both antioxidant and pro-oxidant effects under different
environmental conditions (21). In vitro assays have shown that
EGCG is capable to scavenge different reactive species, such as
the superoxide anion and hydroxyl radicals (35). On the other
hand, the EGCG autoxidation can generate EGCG radical,
superoxide radical, and hydrogen peroxide species (34, 36). It
has been reported that one molecule of EGCG can produce
about two molecules of hydrogen peroxide after overnight
incubation in phosphate buffer, pH 7, at a concentration of
0.022–0.22 mM (36). The different effects reported in the liter-
ature might be interpreted in terms of EGCG concentration
relative to oxygen partial pressure (21). Although DA and
EGCG have distinct AS-binding properties in terms of affinity,
conformational selectivity, and conformational effects (20),
protein modification by the two ligands takes place with only
minor differences in the kinetics of the individual methionine
residues, in line with a mechanism involving H2O2 production
Figure 6. Tertiary-structure transitions induced by ligand binding to AS by IM-MS. Collision cross-section obtained from the 11 (A) or 8 (B) charge
states of oMet0 andoMet4 complexeswith ligandsby IM-MSexperiments, as a functionof thenumber of bound ligandmolecules (oMet0,black symbols; oMet4,
red symbols). The relative intensities of the signals are expressed by a color scale (inset). Conformers are named by lowercase, italic letters. Representative data
from at least three replicas are shown.
-Synuclein oxidation hinders secondary structure formation
5662 J. Biol. Chem. (2019) 294(14) 5657–5665
 at SISSA
 on January 31, 2020
http://w
w
w
.jbc.org/
D
ow
nloaded from
 
in the presence of either ligand. This is consistent with the fact
that AS incubation with H2O2 results in the same covalent
modifications as those reported here (data not shown) (37).
oMet4 AS is endowed with a strongly reduced propensity to
form amyloid fibrils relative to oMet0 (7). It has been suggested
that this feature might derive from a reduced tendency to form
a -type secondary structure. However, oMet0 and oMet4 AS
display very similar structural properties, as assessed by various
spectroscopic methods under several different conditions (7,
14, 16, 17). The same has been reported here for the highly
helical conformation at high TFE concentrations, the -rich
state in the presence of high MeOH concentrations, and the
highly disordered state in aqueous buffers in the absence of
ligands. Furthermore, the thermal stability of the intrinsic
structural elements of the two protein variants is very similar.
On the other hand, the CD results reported here show that
differences emerge at intermediate points of the titrations with
TFE and MeOH, in which the oxidized protein consistently
displays a higher disorder content than unmodified AS. Such a
trend is in agreement with FTIR data, showing restricted
response to dehydration. The latter condition has been already
shown to induce formation of intermolecular -sheets (29).
At the tertiary-structure level, oxidized AS displays slight
amplification of ligand-induced conformational changes, par-
ticularly with EGCG. This ligand stabilizes AS-collapsed con-
formations, as shownby IM-MS, and this effect ismore remark-
able in the oxidized protein. This behavior could seem in
contrast with the reduced chain flexibility caused by methio-
nine oxidation (38). This result suggests that the change in side
chain chemical properties is the most relevant effect of oxida-
tion and hints, in turn, to a predominant role of polar interac-
tions mediating chain compaction in the presence of this poly-
phenolic ligand.
The lower propensity of oMet4 AS to acquire ordered sec-
ondary structure, and particularly -sheets, is relevant in the
context of AS amyloid aggregation and could explain the inhi-
bition of fibrillation potential bymethionine oxidation. Indeed,
fibrils, on-pathway oligomers, and off-pathway oligomers are
characterized by different type and content of secondary-struc-
ture elements (16, 39). Even minor differences in the relative
stability of alternative conformers could strongly affect the evo-
lution of ensembles governed by competing pathways.
Experimental procedures
Chemicals and proteins
Ammonium acetate, ammonium hydroxide, DA, EGCG,
acetonitrile, formic acid, acetic acid, chymotrypsin, ammonium
bicarbonate, monosodium phosphate, disodium phosphate,
TFE, and MeOH were purchased from Sigma. WT human AS
without any tag (average mass 14460.1 Da) was expressed in
recombinant form and purified as previously described (40).
AS oxidation analysis by ESI-MS
Samples containing 70 M AS were incubated at 37 °C in 50
mM ammonium acetate, pH 7.0, undermild agitation (400 rpm)
in the presence of 2 mM DA or 200 M EGCG (20). Aliquots
were taken every 8 h for 3 days, purified from salts and ligands
by reversed-phase chromatography (Zip TipC4Millipore, Bur-
lington, MA), and analyzed by ESI-MS to determine AS oxida-
tion levels. Part of the purified aliquots were frozen, dried,
and resuspended for in-solution digestion by chymotrypsin
(Sigma). Digestion were carried out at 1:50 enzyme:substrate
ratio (w/w), in 50 mM ammonium bicarbonate, and incubation
at 37 °C for 18 h. The resulting peptides were desalted by Zip
Tip C18 (Millipore) and analyzed by ESI-MS and ESI-MS/MS,
to map modifications and monitor oxidation kinetics.
MS spectra of intact protein or chymotryptic peptides were
collected in positive-ionmode, using a hybrid quadrupole-TOF
mass spectrometer (QSTAR-Elite, AB Sciex, Foster City, CA)
equipped with a nano-ESI source. Samples were infused at
room temperature by metal-coated borosilicate capillaries
(Thermo Fisher Scientific, Waltham, MA) with a medium-
length emitter tip of 1-m internal diameter. The main instru-
mental parameters were set as follows: ion spray voltage, 1.1–
1.2 kV; declustering potential, 100 V; curtain-gas pressure,
20 p.s.i. Final spectrawere obtained by averaging the signal over
2min acquisition. All the datawere processed usingAnalystQS
2.0 (AB Sciex) software. Oxidation ratios for chymotryptic pep-
tides were calculated as ratios between the peptide peak–
height in MS spectra.
Trypsin (Promega,Madison,WI) digestionwas performed at
1:50 enzyme:substrate ratio (w/w), in 100 mM ammonium
bicarbonate, and incubation at 37 °C for 18 h. Trypsin-digested
mixtures were analyzed by the Eksigent nanoLC-Ultra 2D Sys-
tem (Eksigent, ABSCIEX,Dublin, CA) on ananoLCcolumn (75
m 15 cm 3C18-CL, 3 m, 120 Å), through a 35-min gradi-
ent of 5–60% of eluent B (eluent A, 0.1% formic acid in water;
eluent B, 0.1% formic acid in acetonitrile), at a flow rate of 300
nl/min. Mass spectra were acquired using a LTQ-Orbitrap XL-
ETD mass spectrometer (Thermo Fisher Scientific, San José,
CA), equipped with a nanospray ionization source. Nanospray
was achieved using a coated fused silica emitter (New Objec-
tive,Woburn,MA) (360mouter diameter/50minner diam-
eter; 730mtip inner diameter) held at 1.6 kV. The ion transfer
capillary was held at 220 °C. Full mass spectra were recorded in
positive ion mode over a 400–1600m/z range and with a reso-
lution setting of 30,000 FWHM and scan rate of 2 spectra/s,
followed by five low-resolution MS/MS events, sequentially
generated in a data-dependent manner on the top five most
intense ions selected from the fullMS spectrum, using dynamic
exclusion for MS/MS analysis. All data generated were
searched using the Sequest HT search engine contained in the
Thermo Scientific Proteome Discoverer software, version 2.1.
Methionine oxidation was set as dynamic modification. Oxida-
tion extent was calculated as the ratio between peptide spec-
trum matches of the oxidized and non-oxidized forms. This
method counts the number of MS/MS spectra identified for a
given peptide and, consequently, its relative abundance, in each
analyzed condition.
AS secondary structure by CD and FTIR
oMet4 AS and oMet0 AS were buffer-exchanged by Zeba
Spin desalting columns (Thermo Fisher Scientific) with elution
in 50 mM sodium phosphate, pH 7.0. CD spectra in the far-UV
range (190–260 nm) were acquired on a J-815 spectropolarim-
eter (JASCO Corp., Tokyo, Japan), equipped with a Peltier sys-
-Synuclein oxidation hinders secondary structure formation
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tem for temperature control. Samples were clarified by centrif-
ugation at 10,000  g and measured in 50 mM sodium
phosphate, pH 7.0, in the presence of variable amounts of TFE
or MeOH, employing a protein concentration of 10 M and
quartz cuvette of 1-mm path length. The following instrumen-
tal settings were applied: data pitch, 0.1 nm; scan speed, 20
nm/min; bandwidth, 1 nm; accumulation spectra, 2.
For FTIR analyses, the oMet0 and oMet4 AS samples were
measured in the form of a semidry film or in D2O solution. In
particular, 2 l of AS samples at 5 mg/ml of protein concentra-
tion in 50 mM sodium phosphate, pH 7.0, were deposited on a
BaF2 window and dried at room temperature, to obtain a solid
film. The FTIR absorption spectra were then acquired in trans-
mission mode by means of a Varian 670-IR FTIR spectrometer
coupled to the Varian 610-IR IRmicroscope (both fromVarian,
Mulgrave VIC, Australia Pty. Ltd.) (41), under the following
instrumental settings: 2 cm1 spectral resolution, 25 kHz scan
speed, 512 scan co-additions, triangular apodization, mercury
cadmium telluride nitrogen-cooled detector, and a variable
aperture of the microscope of 100 m 100 m. Considering
that the total amount of protein can still be different even
within a fixed surface area, due to variability in film thickness,
we compared only spectra of oMet0 and oMet4 AS with similar
Amide I areas. Because solvent evaporation can induce protein
conformational changes and aggregation (29), it is particularly
important to compare samples with similar protein contents.
For conventional transmission-mode measurements of the
proteins inD2O solutions (30, 31), lyophilized oMet0 andoMet4
AS samples were resuspended in deuterated 50 mM sodium
phosphate, pH 7.0, at a protein concentration of 5 mg/ml. A
sample volume of 20l was placed in a temperature-controlled
transmission cell with two BaF2 windows separated by a
100-mTeflon spacer and the spectra were collected using the
Varian 670-IR FTIR spectrometer as described above. To
increase the signal-to-noise ratio, 1,000 scan co-additions were
employed. FTIR spectra were collected during the thermal
treatment of the protein solutions from25 to 100 °C at a heating
rate of 0.4 °C/min. Protein absorption was obtained after sub-
traction of solvent absorption, measured under the same con-
ditions. The FTIR spectra were baseline-corrected and the sub-
traction of residual vapor signals was also performed when
necessary (31). All the absorption spectra were normalized
for the Amide I band area. Second-derivative spectra were
obtained after the smoothing of the measured spectra by the
Savitzky Golay algorithm (42). Data collection and analysis
were performed using the Resolutions-Pro software (Varian,
Mulgrave VIC, Città, Australia Pty. Ltd.).
SDS-PAGE
Samples after the 72-h incubation were centrifuged for 10
min at 10,000  g to separate soluble and insoluble protein
fractions. Pellets were resuspended into a volume identical to
the supernatant (40 l), and 6 l of each fraction were run on
14% PAGE on a mini-gel apparatus (Bio-Rad), according to the
Laemmli protocol for SDS-PAGE (43) and stained by SimplyBlu
SafeStain (Life Technologies).
Ligand binding by nativeMS and IM-MS
oMet4 AS was obtained by incubating 70 M oMet0 AS in 50
mM ammonium acetate, pH 7.0, 2 mM DA for 72 h at 37 °C
under mild agitation. The resulting sample was buffer
exchanged using 7k MWCO Zeba Spin desalting columns
(Thermo Fisher Scientific) with elution in 50 mM ammonium
acetate, pH 7.0. oMet0 and oMet4 AS were mixed at final
equimolar concentrations (20 M) and analyzed by nano-ESI-
(IM)-MS in the presence of 3 mM DA or 150 M EGCG.
Nano-ESI-(IM)-MS measurements were performed on a
Synapt G2 HDMS (Waters, Manchester, UK) equipped with a
nano-ESI sample source. Home-made gold-coated borosilicate
capillaries were used to infuse the samples at room tempera-
ture. The main instrumental settings were: capillary voltage,
1.5–1.8 kV; sampling cone, 25 V; extraction cone, 1 V; trap, CE
4 V; transfer, CE 0 V; trap bias, 42 V. Gas pressures used
throughout the instrument were: source, 2.8 mbar; trap cell,
2.4  102 mbar; IM cell, 3.0 mbar; transfer cell, 2.5  102
mbar. Spectra were analyzed using Masslynx version 4.1 and
Driftscope version 2.3 (Waters, Manchester, UK).
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